Loading…
Reported covered position: Office of Senator Ernest F. Hollings (D-SC), State Director; US Department of Education, Special Assistant to the Secretary; The White House, Office of the First Lady, Deputy Director of Scheduling & Advance (detailed from US Department of Education)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Think Tank and Nonprofit Foreign Influence Disclosure Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHLOW CORPORATION via PHLOW CORPORATION
2026 · second_quarter · Q2
FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R.9260); FY27 Department of Defense Appropriations (H.R.9495)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Source: Senate LDA
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R.9260); FY27 Department of Defense Appropriations (H.R.9495)
Department of Defense Appropriations Act, 2027
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R.9260); FY27 Department of Defense Appropriations (H.R.9495)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Think Tank and Nonprofit Foreign Influence Disclosure Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Department of Defense Appropriations Act, 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587) FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Department of Defense Appropriations Act, 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587) FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
National Defense Authorization Act for Fiscal Year 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
National Defense Authorization Act for Fiscal Year 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587) FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Department of Defense Appropriations Act, 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587) FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Department of Defense Appropriations Act, 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Promoting Strong Native Families and Children Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587) FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Promoting Strong Native Families and Children Act
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Department of Defense Appropriations Act, 2025
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
Department of Defense Appropriations Act, 2025
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
Department of Defense Appropriations Act, 2025
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025
Client: PHLOW CORPORATION · Firm: PHLOW CORPORATION
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE
PHLOW CORPORATION via PHLOW CORPORATION
2026 · first_quarter · Q1
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (no bill numbers); FY27 Department of Defense Appropriations (no bill numbers)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE
PHLOW CORPORATION via PHLOW CORPORATION
2025 · fourth_quarter · Q4
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587); FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE
PHLOW CORPORATION via PHLOW CORPORATION
2025 · third_quarter · Q3
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R. 5304/S.2587) FY26 Department of Defense Appropriations (H.R. 4016/S.2572/S.2296/S.4638)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE
PHLOW CORPORATION via PHLOW CORPORATION
2025 · second_quarter · Q2
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations FY26 Department of Defense Appropriations
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act. (identical legislation)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE
PHLOW CORPORATION via PHLOW CORPORATION
2025 · first_quarter · Q1
FY26 Labor, Health and Human Services, Education, and Related Agencies Appropriations FY26 Department of Defense Appropriations
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHLOW CORPORATION via PHLOW CORPORATION
2024 · fourth_quarter · Q4
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
PHLOW CORPORATION via PHLOW CORPORATION
2024 · third_quarter · Q3
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
PHLOW CORPORATION via PHLOW CORPORATION
2024 · second_quarter · Q2
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
RAPID Reserve Act (S. 2510); Rolling Active Pharmaceutical Ingredient and Drug Reserve Act (H.R. 6802); Administrations activities related to pharmaceutical supply chain and domestic capacity; DOD activities related to pharmaceutical and medical countermeasure supply chain for the warfighter
FY2025 Labor HHS Education Appropriations bill (H.R. 9029); FY2025 Defense Appropriations bill (H.R. 8774); Pandemic All Hazards Preparedness Act Reauthorization
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE